THURSDAY
Recursion Pharmaceuticals, Inc. - Class A
SCoRE: 47
LAST PRICE - AT THE CLOSE
RXRX is DOWN -42% since the begininning of the year
RXRX is DOWN -15% BELOW 20 day SMA
RXRX is DOWN -31% BELOW 200 day SMA
PROFITABLE: NO
EPS: $-0.34
EARNINGS MOMENTUM: YES
0.17% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
 |
THE STOCK IS 86.6% AWAY FROM ALL-TIME HIGHS OF $42.81 |
 |
RXRX IS DOWN -42% SINCE THE BEGINNING OF THE YEAR |
 |
RXRX IS DOWN -12% OVER THE PAST 12 MONTHS |
 |
RXRX IS DOWN -9% OVER THE PAST 1 MONTH |
 |
28% OF ALL RXRX INVESTORS ARE BETTING AGAINST RXRX |
 |
NUM INVESTORS SHORT RXRX HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|---|---|
 | New premarket high. ... | 11/21 |
 | New premarket low. ... | 11/21 |
 | Down 6% for the day. | 11/21 |
 | Trading 14% above ex... | 11/21 |
 | Trading 8% below exp... | 11/21 |
 |
RXRX moved up 0 in the previous minute |
 |
RXRX is up 0.17 over the last hour |
 |
RXRX is up 20.4% over the last 5 days |
 |
RXRX is 14 above its 8 day SMA |
| $5.62 |   DAY |
$6.03 |
| $5.70 |  PREVIOUS DAY |
$6.37 |
| $5.70 | WEEK |
$7.58 |
| $5.70 | MONTH |
$8.49 |
| $5.70 | YEAR |
$15.74 |
RXRX is mentioned N/A less than normal on 
RXRX is mentioned N/A times in an average day on 
